Gene amplification in ductal carcinoma in situ of the breast.
about
Estrogen receptor alpha gene amplification in breast cancer: 25 years of debateAppraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breastPI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma.GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor.Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genesAssessment of palindromes as platforms for DNA amplification in breast cancerPrecancerous Lesions of the BreastFGFR1 is amplified during the progression of in situ to invasive breast carcinomaWhat is the malignant nature of human ductal carcinoma in situ?PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.Progression from ductal carcinoma in situ to invasive breast cancer: revisited.ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry.Ductal carcinoma in situ - update on risk assessment and management.Comparison of HER2 amplification status among breast cancer subgroups offers new insights in pathways of breast cancer progression.Genome evolution in ductal carcinoma in situ: invasion of the clones.Microinvasive breast cancer: pathological parameters, cancer subtypes distribution, and correlation with axillary lymph nodes invasion. Results of a large single-institution series.Absence of estrogen receptor alpha (ESR1) gene amplification in a series of breast cancers in Taiwan.Accurate assessment of HER2 gene status for invasive component of breast cancer by combination of immunohistochemistry and chromogenic In Situ hybridization.Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.Breast cancers with EGFR and HER2 co-amplification favor distant metastasis and poor clinical outcome.Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype.Impact of an In Situ Component on Outcome After In-Breast Tumor Recurrence in Patients Treated with Breast-Conserving Therapy.HER-2/neu gene amplification in carcinoma ex pleomorphic adenoma in relation to progression and prognosis: a chromogenic in-situ hybridization study.Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study.
P2860
Q24273274-8E1F559B-99C7-41C2-AA36-D2F2117C1E93Q28083103-BC9CD883-F0B5-4198-AA6D-5628D923663AQ33587930-D0E1DCD8-3572-43DA-9E1B-765DBB3ADB30Q35051560-BB94D94C-3691-4313-B33F-5979B57C7D06Q35085978-1ED45977-8362-4069-B4C4-1C27A50EC2BFQ35694379-3F663571-0063-4678-ABF7-C64D08AD60ABQ35940061-01BC305B-FCE8-4D04-A1B9-A781BBBBDE49Q36924421-4ECC29EA-69AC-4E7B-BD34-266A68650D47Q37130512-382B628B-1158-4718-9F8B-798316097A85Q37589094-D576D9A7-4CB9-46E5-B9A4-21F8922BD610Q38124521-7E18AC01-6319-438E-BCB2-9618B0F85A18Q38403294-5AC3AB38-3BF5-4D6F-8C0E-6AB1EEDAD03DQ38696796-3E56BEE0-04F4-41BE-A4CF-CB41998A97E4Q38752161-D02B2DDD-FCD9-488A-8577-0AC5BEF1678FQ39012815-B4433F27-8238-4C45-A1A2-CC9184560B24Q40931587-B85B7AC9-B1C7-4B62-B1A3-F00EFE0A4E78Q44823361-878B8F2C-A297-46A1-A300-DB2FA0293E41Q46565660-1A8D1AAE-8029-4BE9-A5B0-F6E8CA04D2B5Q46699535-980F943B-B521-475A-A89A-DCC5A410572CQ47135806-24B64E38-604C-4F87-9C96-76D6264BFFE3Q49061414-99557C12-5BCA-426F-AD5B-DFB9B20AB009Q52822443-0DD86149-F043-4A62-8113-AA173192198DQ54518663-125B66D9-E62D-4DBC-B6D3-80EE1635BEFFQ55223470-2422A594-FAF2-475C-B8E0-6F03B6ADD019
P2860
Gene amplification in ductal carcinoma in situ of the breast.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Gene amplification in ductal carcinoma in situ of the breast.
@en
Gene amplification in ductal carcinoma in situ of the breast.
@nl
type
label
Gene amplification in ductal carcinoma in situ of the breast.
@en
Gene amplification in ductal carcinoma in situ of the breast.
@nl
prefLabel
Gene amplification in ductal carcinoma in situ of the breast.
@en
Gene amplification in ductal carcinoma in situ of the breast.
@nl
P2093
P2860
P1476
Gene amplification in ductal carcinoma in situ of the breast.
@en
P2093
C Bokemeyer
L Burkhardt
M Choschzick
P2860
P2888
P304
P356
10.1007/S10549-009-0675-8
P407
P577
2009-12-22T00:00:00Z
P5875
P6179
1011394181